FDA warns against use of Skippack Medical Lab COVID-19 Antigen Test
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
•
May 11, 2022, 10:40 AM
•
Updated 881 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
29ds ago
Hometown Heroes in the Hudson Valley
76ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
220ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
241ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
368ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
369ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
29ds agoHometown Heroes in the Hudson Valley
76ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
220ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
241ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
368ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
369ds agoThe
U.S. Food and Drug Administration is warning people not to use the
Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
According to the FDA, the test is not authorized, cleared, or approved by the FDA for distribution or use in the United States.
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
The FDA says it has not received reports of injuries or death associated with use of the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
According to the FDA, the test is not authorized, cleared, or approved by the FDA for distribution or use in the United States.
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
The FDA says it has not received reports of injuries or death associated with use of the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
More from News 12
0:33
State police: Violent dispute leaves 1 fatally shot, 1 stabbed in Pleasant Valley
1:29
Voters to decide on $110 million bond for Clarkstown School District
2:12
Made in the Hudson Valley: Ortiz Cigars brings Dominican family tradition to Rockland County
1:26
Oct. 7 memorial service held in Rockland County
1:27
Yonkers Chamber of Commerce elects its first Latino president
1:31
